Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis. Lancet. 2021;398:1359–76.

Article  PubMed  Google Scholar 

Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49:1017–44.

Article  PubMed  Google Scholar 

Mózes FE, Lee JA, Selvaraj EA, et al. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022;71:1006–19.

Article  PubMed  Google Scholar 

Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol. 2015;50:76–84.

Article  CAS  PubMed  Google Scholar 

Shirabe K, Bekki Y, Gantumur D, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819–26.

Article  CAS  PubMed  Google Scholar 

Abe M, Miyake T, Kuno A, et al. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease. J Gastroenterol. 2015;50:776–84.

Article  CAS  PubMed  Google Scholar 

Umemura T, Joshita S, Sekiguchi T, et al. Serum wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosis. Am J Gastroenterol. 2015;110:857–64.

Article  CAS  PubMed  Google Scholar 

Narimatsu H. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics. Expert Rev Proteomics. 2015;12:683–93.

Article  CAS  PubMed  Google Scholar 

Matsumoto K, Yoshimoto J, Sugo H, et al. Relationship between the histological degrees of hepatitis and the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis C. Hepatol Res. 2002;23:196–201.

Article  PubMed  Google Scholar 

Ueno T, Kodama T, Noguchi Y, et al. Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis. Pediatr Surg Int. 2019;35:1065–70.

Article  PubMed  Google Scholar 

Mak LY, Wong DK, Seto WK, et al. Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection. Hepatol Int. 2019;13:148–56.

Article  PubMed  Google Scholar 

Alkhouri N, Johnson C, Adams L, et al. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis. PLoS ONE. 2018;13: e0202226.

Article  PubMed  PubMed Central  Google Scholar 

Shao X, Uojima H, Setsu T, et al. Usefulness of autotaxin for the complications of liver cirrhosis. World J Gastroenterol. 2020;26:97–108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Migita K, Horai Y, Kozuru H, et al. Serum cytokine profiles and Mac-2 binding protein glycosylation isomer (M2BPGi) level in patients with autoimmune hepatitis. Medicine (Baltimore). 2018;97: e13450.

Article  CAS  PubMed  Google Scholar 

Morio K, Imamura M, Daijo K, et al. Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury. J Gastroenterol. 2017;52:1252–7.

Article  CAS  PubMed  Google Scholar 

Bekki Y, Yoshizumi T, Shimoda S, et al. Hepatic stellate cells secreting WFA+ M2BP: its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2017;32:1387–93.

Article  CAS  PubMed  Google Scholar 

Singh T, Allende DS, McCullough AJ. Assessing liver fibrosis without biopsy in patients with HCV or NAFLD. Cleve Clin J Med. 2019;86:179–86.

Article  PubMed  Google Scholar 

Medvedev R, Ploen D, Hildt E. HCV and oxidative stress: implications for HCV life cycle and HCV-associated pathogenesis. Oxid Med Cell Longev. 2016;2016:9012580.

Article  PubMed  PubMed Central  Google Scholar 

Sirbe C, Simu G, Szabo I, et al. Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms. Int J Mol Sci. 2021;22:13578.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sucher E, Sucher R, Gradistanac T, et al. Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies. J Immunol Res. 2019;2019:9437043.

Article  PubMed  PubMed Central  Google Scholar 

Joshita S, Umemura T, Usami Y, et al. Serum autotaxin is a useful disease progression marker in patients with primary biliary cholangitis. Sci Rep. 2018;8:8159.

Article  PubMed  PubMed Central  Google Scholar 

Nakagawa M, Nawa N, Takeichi E, et al. Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs. J Gastroenterol. 2020;55:990–9.

Article  CAS  PubMed  Google Scholar 

Tangvoraphonkchai K, Suttichaimongkol T, Kularbkaew C, et al. Application of Mac-2 binding protein glycosylation isomer as a non-invasive biomarker for probing liver disease. Sci Rep. 2022;12:6757.

Article  CAS  PubMed  PubMed Central  Google Scholar